TrademarkDir
FUROSCIX DIRECT
LIVE

Serial Number

97681853

Owner

scPharmaceuticals Inc.

Attorney

Julie Nichols Matthews

First Use Date

Feb 27, 2023

Filing Date

Nov 17, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FUROSCIX DIRECT Trademark

Serial Number: 97681853 • Registration: 7289009

FUROSCIX DIRECT is a trademark filed by scPharmaceuticals Inc. on November 17, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

scPharmaceuticals Inc. (11 trademarks)

131 Hartwell Avenue, Suite 215
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

November 17, 2022

Registration Date

January 23, 2024

First Use Anywhere

February 27, 2023

First Use in Commerce

February 27, 2023

Published for Opposition

April 11, 2023

Goods & Services

Financial administration of medication reimbursement programs and services; Financial administration of pharmacy reimbursement programs and services

home delivery of medical products

Business administration of medication reimbursement programs and services; Business administration of pharmacy reimbursement programs and services

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 30, 2026 ASCK
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Dec 16, 2025 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 24, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 22, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Oct 22, 2025 ES7R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 16, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 15, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 15, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 14, 2023 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2023 EXRA
USE AMENDMENT FILED
Dec 5, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 5, 2023 EISU
SOU EXTENSION 1 GRANTED
Dec 5, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 5, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 5, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 6, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2023 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jan 24, 2023 CEPE
ASSIGNED TO LIE
Jan 24, 2023 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 23, 2023 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 23, 2023 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jan 23, 2023 CPEA
ASSIGNED TO EXAMINER
Jan 13, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 9, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2022 NWOS
NEW APPLICATION ENTERED
Nov 21, 2022 NWAP

Related Trademarks

More from this Owner

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

POWERED BY PASSION. DRIVEN BY PATIENT CARE.

FUROSCIX READYFLOW

FUROSCIX READYFLOW